Childhood acute myeloid leukemia with bone marrow eosinophilia caused by t(16;21)(q24;q22) |
| |
Authors: | Nozomu Kawashima Akira Shimada Takeshi Taketani Yasuhide Hayashi Nao Yoshida Kimikazu Matsumoto Yoshiyuki Takahashi Seiji Kojima Koji Kato |
| |
Affiliation: | Division of Hematology/Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, 3-35, Michishita-cho, Nakamura-ku, Nagoya, Aichi, 453-8511, Japan. kwnozomu@med.nagoya-u.ac.jp |
| |
Abstract: | Acute myeloid leukemia with abnormal bone marrow eosinophilia (AML-M4Eo) is often reported in core binding factor (CBF) leukemia, with translocations such as inv(16)(p13q22), t(16;16)(p13;q22) or t(8;21)(q22;q22); however, it is rarely reported with t(16;21)(q24;q22), which produces the RUNX1-CBFA2T3 (AML1-MTG16) chimera. The similarity between this chimera and RUNX1-RUNXT1 (AML1-MTG8) by t(8;21)(q22;q22) remains controversial. Adult leukemia with t(16;21)(q24;q22) was primarily therapy related, and shows poor prognosis; however, pediatric AML with this translocation was quite rare and tended to be de novo AML. We present here a 4-year-old boy with de novo AML-M4Eo and t(16;21)(q24;q22). He received chemotherapy and survived for more than 70 months without transplantation. We speculated that pediatric AML with t(16;21)(q24;q22) showed favorable prognosis, as with t(8;21)(q22;q22). |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|